Stereotactic body radiation therapy for early-stage non-small cell lung cancer: a single-institutional retrospective analysis of outcomes and prognostic factors
SBRT achieves durable survival in early-stage NSCLC at our center. Central/lower lobe tumors, bigger tumors, smoking history, and medical inoperable independently predict inferior survival, emphasizing the need for personalized dose escalation strategies or combined treatment modalities.
Authors
- Jiajia Dong (ORCID: https://orcid.org/0000-0001-9908-2699)
- Wei Huang (ORCID: https://orcid.org/0000-0001-9561-5099)
- Zhongtang Wang (ORCID: https://orcid.org/0000-0003-3153-6775)
- Bin Zhang (ORCID: https://orcid.org/0000-0002-9549-5653)
- Chunhui Li (ORCID: https://orcid.org/0000-0001-8085-4046)
- Baosheng Li (ORCID: https://orcid.org/0000-0002-1515-2918)
- Dan Han (ORCID: https://orcid.org/0000-0002-0408-9175)
- Chengrui Fu
- Chengxin Liu (ORCID: https://orcid.org/0000-0003-2962-0820)
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Shuozhou Central Hospital (CN)
- Shandong First Medical University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.3389/fonc.2025.1591420
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00